pseudoephedrine / triprolidine Oral Tablet [Wal-Act]

RxCUI
1014653
RxNorm name
pseudoephedrine / triprolidine Oral Tablet [Wal-Act]
Term type
SBDF
Status
Active
Updated
2026-07-27 06:53:14

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
112010
Active start
112010
Multiple ingredient
YES
Branded
YES

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
triprolidine10849
pseudoephedrine8896

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRpseudoephedrine / triprolidine Oral Tablet [Wal-Act]NAMES
RxNorm Namepseudoephedrine / triprolidine Oral Tablet [Wal-Act]NAMES
TTYSBDFATTRIBUTES
RxCUI1014653CODES

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCR06AXOther antihistamines for systemic useATC1-4triprolidine
ATCR01BASympathomimeticsATC1-4pseudoephedrine
FDASPLN0000175552alpha-Adrenergic AgonistEPChas_epcpseudoephedrine
MEDRTD054199PseudoephedrineCHEMhas_ingredientpseudoephedrine
MEDRTD054199PseudoephedrineCHEMhas_ingredientpseudoephedrine hydrochloride
MEDRTD014311TriprolidineCHEMhas_ingredienttriprolidine hydrochloride
MEDRTD014311TriprolidineCHEMhas_ingredienttriprolidine
MEDRTD001249AsthmaDISEASEmay_treatpseudoephedrine
MEDRTD001249AsthmaDISEASEmay_treatpseudoephedrine hydrochloride
MEDRTD003139Common ColdDISEASEmay_treatpseudoephedrine hydrochloride
MEDRTD003139Common ColdDISEASEmay_treatpseudoephedrine
MEDRTD003233Conjunctivitis, AllergicDISEASEmay_treattriprolidine hydrochloride
MEDRTD003233Conjunctivitis, AllergicDISEASEmay_treattriprolidine
MEDRTD003327Coronary DiseaseDISEASEci_withtriprolidine hydrochloride
MEDRTD003327Coronary DiseaseDISEASEci_withtriprolidine
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriprolidine hydrochloride
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriprolidine
MEDRTD004342Drug HypersensitivityDISEASEci_withpseudoephedrine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withpseudoephedrine
MEDRTD004342Drug HypersensitivityDISEASEci_withtriprolidine
MEDRTD004342Drug HypersensitivityDISEASEci_withtriprolidine hydrochloride
MEDRTD012220RhinitisDISEASEmay_treattriprolidine hydrochloride
MEDRTD012220RhinitisDISEASEmay_treattriprolidine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatpseudoephedrine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatpseudoephedrine hydrochloride
MEDRTD012852SinusitisDISEASEmay_treatpseudoephedrine
MEDRTD012852SinusitisDISEASEmay_treatpseudoephedrine hydrochloride
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moapseudoephedrine hydrochloride
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moapseudoephedrine
MEDRTN0000000245Adrenergic beta-AgonistsMOAhas_moapseudoephedrine
MEDRTN0000000245Adrenergic beta-AgonistsMOAhas_moapseudoephedrine hydrochloride
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moatriprolidine hydrochloride
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moatriprolidine
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moatriprolidine
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moapseudoephedrine
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moatriprolidine hydrochloride
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moapseudoephedrine hydrochloride
MEDRTN0000008322BronchodilationPEhas_pepseudoephedrine hydrochloride
MEDRTN0000008322BronchodilationPEhas_pepseudoephedrine
MEDRTN0000008657Decreased Histamine ActivityPEhas_petriprolidine
MEDRTN0000008657Decreased Histamine ActivityPEhas_petriprolidine hydrochloride
MEDRTN0000009908VasoconstrictionPEhas_pepseudoephedrine
MEDRTN0000009908VasoconstrictionPEhas_pepseudoephedrine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSBDF
CODESRxCUI1014653
NAMESRXNAV_STRpseudoephedrine / triprolidine Oral Tablet [Wal-Act]
NAMESRxNorm Namepseudoephedrine / triprolidine Oral Tablet [Wal-Act]